These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24363402)

  • 21. Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation.
    Mazerolles F; Stolzenberg MC; Pelle O; Picard C; Neven B; Fischer A; Magerus-Chatinet A; Rieux-Laucat F
    Front Immunol; 2018; 9():718. PubMed ID: 29686686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS).
    Teachey DT; Manno CS; Axsom KM; Andrews T; Choi JK; Greenbaum BH; McMann JM; Sullivan KE; Travis SF; Grupp SA
    Blood; 2005 Mar; 105(6):2443-8. PubMed ID: 15542578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variations of the UNC13D gene in patients with autoimmune lymphoproliferative syndrome.
    Aricò M; Boggio E; Cetica V; Melensi M; Orilieri E; Clemente N; Cappellano G; Buttini S; Soluri MF; Comi C; Dufour C; Pende D; Dianzani I; Ellis SR; Pagliano S; Marcenaro S; Ramenghi U; Chiocchetti A; Dianzani U
    PLoS One; 2013; 8(7):e68045. PubMed ID: 23840885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FcRγ promotes T cell apoptosis in Fas-deficient mice.
    Juvet SC; Thomson CW; Kim EY; Joe B; Adeyi O; Zhang L
    J Autoimmun; 2013 May; 42():80-93. PubMed ID: 23313147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FcRγ controls the fas-dependent regulatory function of lymphoproliferative double negative T cells.
    Juvet SC; Thomson CW; Kim EY; Han M; Zhang L
    PLoS One; 2013; 8(6):e65253. PubMed ID: 23762329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.
    Ruiz-García R; Mora S; Lozano-Sánchez G; Martínez-Lostao L; Paz-Artal E; Ruiz-Contreras J; Anel A; González-Granado LI; Moreno-Pérez D; Allende LM
    Pediatr Res; 2015 Dec; 78(6):603-8. PubMed ID: 26334989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal thymic maturation and lymphoproliferation in MRL-Fas
    Ashman RF; Singh N; Lenert PS
    Lupus; 2017 Jun; 26(7):734-745. PubMed ID: 27837196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting cytokines in ALPS: it's FAShionable.
    Teachey DT
    Blood; 2014 Feb; 123(8):1116-8. PubMed ID: 24558187
    [No Abstract]   [Full Text] [Related]  

  • 29. Double negative (DN) αβ T cells: misperception and overdue recognition.
    Martina MN; Noel S; Saxena A; Rabb H; Hamad AR
    Immunol Cell Biol; 2015 Mar; 93(3):305-10. PubMed ID: 25420721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
    Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma.
    Kaya Z; Işık M; Oruklu N; Kirkiz S; Bağrıaçık EÜ; Allende LM; Díaz-Madroñero MJ; Ruiz-García R; Pınarlı FG; Göçün Uyar P; Koçak Ü
    Turk J Haematol; 2021 Jun; 38(2):145-150. PubMed ID: 33375216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.
    Aspinall AI; Pinto A; Auer IA; Bridges P; Luider J; Dimnik L; Patel KD; Jorgenson K; Woodman RC
    Blood Cells Mol Dis; 1999; 25(3-4):227-38. PubMed ID: 10575548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation of FAS, XIAP, and UNC13D genes in a patient with a complex lymphoproliferative phenotype.
    Boggio E; Aricò M; Melensi M; Dianzani I; Ramenghi U; Dianzani U; Chiocchetti A
    Pediatrics; 2013 Oct; 132(4):e1052-8. PubMed ID: 24043286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis.
    Bettinardi A; Brugnoni D; Quiròs-Roldan E; Malagoli A; La Grutta S; Correra A; Notarangelo LD
    Blood; 1997 Feb; 89(3):902-9. PubMed ID: 9028321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
    Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
    J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome.
    Völkl S; Rensing-Ehl A; Allgäuer A; Schreiner E; Lorenz MR; Rohr J; Klemann C; Fuchs I; Schuster V; von Bueren AO; Naumann-Bartsch N; Gambineri E; Siepermann K; Kobbe R; Nathrath M; Arkwright PD; Miano M; Stachel KD; Metzler M; Schwarz K; Kremer AN; Speckmann C; Ehl S; Mackensen A
    Blood; 2016 Jul; 128(2):227-38. PubMed ID: 27099149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe RAS-Associated Lymphoproliferative Disease Case with Increasing αβ Double-Negative T Cells with Atypical Features.
    Kurita D; Shiba N; Ohya T; Murase A; Shimosato Y; Yoshitomi M; Hattori S; Sasaki K; Nishimura K; Tsujimoto SI; Takeuchi M; Tanoshima R; Kanegane H; Kitagawa N; Ito S
    J Clin Immunol; 2023 Nov; 43(8):1992-1996. PubMed ID: 37644277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective FAS-Mediated Apoptosis and Immune Dysregulation in Gaucher Disease.
    Miano M; Madeo A; Cappelli E; Lanza F; Lanza T; Stroppiano M; Terranova P; Venè R; Bleesing JJH; Di Rocco M
    J Allergy Clin Immunol Pract; 2020; 8(10):3535-3542. PubMed ID: 32702516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective anti-polysaccharide response and splenic marginal zone disorganization in ALPS patients.
    Neven B; Bruneau J; Stolzenberg MC; Meyts I; Magerus-Chatinet A; Moens L; Lanzarotti N; Weller S; Amiranoff D; Florkin B; Bader-Meunier B; Leverger G; Ferster A; Chantrain C; Blanche S; Picard C; Molina TJ; Brousse N; Durandy A; Rizzi M; Bossuyt X; Fischer A; Rieux-Laucat F
    Blood; 2014 Sep; 124(10):1597-609. PubMed ID: 24970930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A genetic disorder of lymphocyte apoptosis involving the fas pathway: the autoimmune lymphoproliferative syndrome.
    Fleisher TA; Straus SE; Bleesing JJ
    Curr Allergy Asthma Rep; 2001 Nov; 1(6):534-40. PubMed ID: 11895618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.